United States - English - NLM (National Library of Medicine)

puretek corporation - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - fluoride ion 1 mg - for once daily self-applied systemic use as a dental caries preventive in pediatric patients. it has been established that ingestion of fluoridated drinking water (1 ppm f*) during the period of tooth development results in a significant decrease in the incidence of dental caries. fluoride chewable tablets were developed to provide systemic fluoride for use as a supplement in pediatric patients from 6 months to 3 years of age and older living in areas where the drinking water fluoride content does not exceed 0.6 ppm f*. fluoride chewable tablets 1.0 mg are contraindicated when the fluoride content of drinking water is 0.3 ppm f* or more and should not be administered to pediatric patients under the age of 6 years. do not administer fluoride chewable tablets (any strength) to pediatric patients under age 6 months.

New Zealand - English - Medsafe (Medicines Safety Authority)

noumed pharmaceuticals limited - sodium fluoride 1.1mg equivalent to 0.5 mg elemental fluoride;   - tablet - 1.1 mg - active: sodium fluoride 1.1mg equivalent to 0.5 mg elemental fluoride   excipient: lactose monohydrate magnesium stearate maize starch - fluoride supplement

Canada - English - Health Canada

dolisos laboratoires s.a. - fluorine - tablet - 8dh - fluorine 8dh - homeopathic products

United States - English - NLM (National Library of Medicine)

petnet solutions, inc. - sodium fluoride f-18 (unii: 9l75099x6r) (fluoride ion f-18 - unii:4m4we5n2ge) - fluoride ion f-18 200 mci in 1 ml - sodium fluoride f 18 injection is indicated for diagnostic positron emission tomography (pet) imaging of bone to define areas of altered osteogenic activity. none. pregnancy category c any radiopharmaceutical including sodium fluoride f 18 injection has a potential to cause fetal harm. the likelihood of fetal harm depends on the stage of fetal development, and the radionuclide dose. animal reproductive and developmental toxicity studies have not been conducted with sodium fluoride f 18 injection. prior to the administration of sodium fluoride f 18 injection to women of childbearing potential, assess for presence of pregnancy. sodium fluoride f 18 injection should be given to a pregnant woman only if clearly needed. it is not known whether sodium fluoride f 18 injection is excreted into human milk. because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to interrupt nursing after administration of sodium fl

United States - English - NLM (National Library of Medicine)

dent-mat holdings, llc. - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o), potassium nitrate (unii: ru45x2jn0z) (nitrate ion - unii:t93e9y2844) - fluoride ion 5 mg in 1 g - fluoridex toothpaste is indicated for use as part of a professional program for the prevention and control of dental caries. do not use in children under 12 years of age unless recommended by a dentist or physician. 8.1 pregnancy pregnancy category b it has been shown that fluoride crosses the placenta of rats, but only 0.01% of the amount administered is incorporated in fetal tissues. animal studies (rats, mice, rabbits) have shown that fluoride is not a teratogen. maternal exposure to 12.2 mg fluoride/kg of body weight (rats) or 13.1 mg/kg of body weight (rabbits) did not affect the litter size or fetal weight and did not increase the frequency of skeletal or visceral malformations. there are no adequate or well controlled clinical studies in pregnant women. however, epidemiological studies conducted in areas with high levels of naturally fluoridated water showed no increase in birth defects. heavy exposure to fluoride during in utero development may result in skeletal fluorosis which becomes evident in chi

United States - English - NLM (National Library of Medicine)

global isotopes, llc d/b/a zevacor molecular - fluoride ion f-18 (unii: 4m4we5n2ge) (fluoride ion f-18 - unii:4m4we5n2ge) - fluoride ion f-18 10 mci in 1 ml - sodium fluoride f18 injection, usp is indicated for diagnostic positron emission tomography (pet) imaging of bone to define areas of altered osteogenic activity. none. pregnancy category c any radiopharmaceutical including sodium fluoride f 18 injection has a potential to cause fetal harm. the likelihood of fetal harm depends on the stage of fetal development, and the radionuclide dose. animal reproductive and developmental toxicity studies have not been conducted with sodium fluoride f 18 injection. prior to the administration of sodium fluoride f 18 injection to women of childbearing potential, assess for presence of pregnancy. sodium fluoride f 18 injection should be given to a pregnant woman only if clearly needed. it is not known whether sodium fluoride f 18 injection is excreted into human milk.  because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to interrupt nursing after administration of sodium

United States - English - NLM (National Library of Medicine)

a-s medication solutions - .alpha.-tocopherol acetate, dl- (unii: wr1wpi7ew8) (.alpha.-tocopherol, dl- - unii:7qwa1rio01), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), niacin (unii: 2679mf687a) (niacin - unii:2679mf687a), pyridoxine (unii: kv2jz1bi6z) (pyridoxine - unii:kv2jz1bi6z), riboflavin (unii: tlm297 - .alpha.-tocopherol, dl- 15 [iu] - off-white to pale yellow, speckled, fruit flavor, round-shaped chewable tablet debossed "sci" on one side and "3" on the other.

United States - English - NLM (National Library of Medicine)

a-s medication solutions - .alpha.-tocopherol acetate, dl- (unii: wr1wpi7ew8) (.alpha.-tocopherol, dl- - unii:7qwa1rio01), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), niacin (unii: 2679mf687a) (niacin - unii:2679mf687a), pyridoxine (unii: kv2jz1bi6z) (pyridoxine - unii:kv2jz1bi6z), riboflavin (unii: tlm297 - each multivitamin with 0.5 mg fluoride tablet contains:

United States - English - NLM (National Library of Medicine)

shertech laboratories, llc - sodium fluoride f-18 (unii: 9l75099x6r) (fluoride ion f-18 - unii:4m4we5n2ge) - fluoride ion f-18 200 mci in 1 ml - sodium fluoride f18 injection, usp is a radioactive diagnostic agent for positron emission tomography (pet) indicated for imaging of bone to define areas of altered osteogenic activity. none. pregnancy category c any radiopharmaceutical including sodium fluoride f18 injection has a potential to cause fetal harm. the likelihood of fetal harm depends on the stage of fetal development, and the radionuclide dose. animal reproduction and developmental toxicity studies have not been conducted with sodium fluoride f18 injection. prior to the administration of sodium fluoride f18 injection to women of childbearing potential, assess for presence of pregnancy. sodium fluoride f18 injection should be given to a pregnant woman only if clearly needed. it is not known whether sodium fluoride f18 injection is excreted into human milk. because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to interrupt nursing after admini

United States - English - NLM (National Library of Medicine)

mayne pharma inc - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - fluoride ion 0.5 mg in 1 ml - it has been established that ingestion of fluoridated drinking water (1 ppm f) during the period of tooth development results in significant decrease in the incidence of dental caries. sodium fluoride drops 0.5 mg were developed to provide systemic fluoride for use as a supplement in pediatric patients from 6 months to age 3 and older, living in areas where the drinking water fluoride level does not exceed 0.6 ppm f. do not use in areas where drinking water exceeds 0.6 ppm f. do not administer to pediatric patients less than 6 months old.